NYSE:GSK | Market Exclusive

Home Tags NYSE:GSK

The FDA Accepts Keytruda From Merck & Co., Inc. (NYSE:MRK) For...

Andy Parker - February 7, 2017 0

Advair, Armonair From Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Gets FDA...

- February 2, 2017 0

NeRRe, A GlaxoSmithKline Plc (NYSE:GSK) Spinout Raises £23 Million For NK...

- January 6, 2017 0

GlaxoSmithKline Plc (NYSE:GSK) Phase 3 Trials Looks Positive: Will Gilead Endure?

Andy Parker - December 21, 2016 0

GlaxoSmithKline plc’s (ADR) (NYSE:GSK) Opens Its First Fully Dedicated Vaccines R&D...

Andy Parker - December 15, 2016 0

GlaxoSmithKline Plc (NYSE:GSK) Wins Approval Of Its Asthma Drug Nucala

- December 2, 2016 0

GlaxoSmithKline Plc (NYSE:GSK) Targeting Blockbuster Sales With Shingles Vaccine On EU...

Andy Parker - November 30, 2016 0

US FDA Clears Propeller Integration With GlaxoSmithKline Plc (NYSE:GSK) Ellipta

- November 8, 2016 0

GlaxoSmithKline plc (ADR) (NYSE:GSK) Teams Up With Fimbrion Therapeutics, Inc.

- October 26, 2016 0

GlaxoSmithKline Plc (NYSE:GSK) Shrugs Skeptics Concerns To Launch Cold Flu Tracker...

- October 18, 2016 0

1...456...9 Page 5 of 9

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NYSE:GSK